Cochlear Ltd
Bad news drags Australian market lower as oil cracks US$100 again
ASX 200 slips 0.8% as oil rebounds above US$100; tech shares crash on AI cost fears, while energy names rise on higher oil prices.
Gold surge helps ASX to a weekly rise
Gold rally fuels ASX weekly gain as miners surge; Catalyst Metals +19%, Genesis Minerals +16%, Newmont +5%, Fortescue slips on China move.
Weekly wrap: ASX loses steam amid hairy chested war rhetoric
ASX slips as Trump-Iran tension persists; IGO sinks 18% on lithium gloom, while energy stocks rally; weekly loss about 1.8%.
Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal
Australia’s competition watchdog, the Australian Competition and Consumer Commission (ACCC) declared it has “significant preliminary competition concerns” regarding Cochlear’s (ASX: COH) proposed $170 million acquisition of Oticon Medical. Cochlear and Oticon Medical manufacture and distribute non-surgical bone conduction devices, surgical bone anchored devices, and cochlear implant hearing devices. The ACCC released a statement fearing the […]